Tectonic Therapeutic (TECX) Cash from Financing Activities (2017 - 2026)
Tectonic Therapeutic (TECX) has 10 years of Cash from Financing Activities data on record, last reported at $847000.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 99.52% to $847000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.9 million, a 101.12% decrease, with the full-year FY2025 number at $173.4 million, up 0.96% from a year prior.
- Cash from Financing Activities reached $847000.0 in Q1 2026 per TECX's latest filing, up from -$141000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for TECX hit a ceiling of $179.7 million in Q2 2024 and a floor of -$6.3 million in Q3 2024.
- A 5-year average of $22.3 million and a median of $1000.0 in 2022 define the central range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 57747.46% in 2023 and fell as far as 32500.0% in 2023.
- Tracing TECX's Cash from Financing Activities over 5 years: stood at $59000.0 in 2022, then surged by 57747.46% to $34.1 million in 2023, then crashed by 103.13% to -$1.1 million in 2024, then soared by 86.81% to -$141000.0 in 2025, then soared by 700.71% to $847000.0 in 2026.
- Business Quant data shows Cash from Financing Activities for TECX at $847000.0 in Q1 2026, -$141000.0 in Q4 2025, and -$457000.0 in Q3 2025.